Investors in Akebia Therapeutics (NASDAQ:AKBA) Have Unfortunately Lost 73% Over the Last Five Years

Yahoo FinanceDec 20 07:27 ET

Express News | Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

ReutersDec 3 16:05 ET

Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

PR NewswireDec 3 16:05 ET

Express News | Akebia Therapeutics Inc - Vafseo Expected to Be Available in U.S. in January 2025

ReutersDec 3 07:08 ET

Express News | U.S. Renal Care Enrolled First Patients in the Voice Collaborative Clinical Trial of Vafseo® (Vadadustat) for Ckd Patients on Dialysis

ReutersDec 3 07:00 ET

U.S. Renal Care Enrolled First Patients in the VOICE Collaborative Clinical Trial of Vafseo (Vadadustat) for CKD Patients on Dialysis

PR NewswireDec 3 07:00 ET